# Money Risk Signoff Update Result

Date: 2026-05-27, Asia/Dubai

Scope: documentation-only signoff tracker update. No production deploy, staging
deploy, production migration, staging migration, production D1 write, staging D1
write, production-copy D1 write, D1 export/import/execute, feature flag change,
dashboard change, business-code change, or financial formula change occurred.

| Signoff Item                             | Previous Status | New Status      | Reason                                                                                                         |
| ---------------------------------------- | --------------- | --------------- | -------------------------------------------------------------------------------------------------------------- |
| SO-006 Money reconciliation approval     | PENDING_REVIEW  | PENDING_REVIEW  | TOP_25 matrix now links money reconciliation evidence to remaining accounting decisions; no approval granted.  |
| SO-007 TOP_25 money risks approval       | MANUAL_REQUIRED | PENDING_REVIEW  | TOP_25 review matrix and Ramadan checklist are now ready for explicit item-by-item decision.                   |
| SO-010 Receivables lifecycle approval    | MANUAL_REQUIRED | MANUAL_REQUIRED | TOP_25 review references receivables/arrears risks, but lifecycle semantics still require accounting approval. |
| SO-011 Receivables allocation approval   | MANUAL_REQUIRED | MANUAL_REQUIRED | Allocation, repayment, overpayment, refund, and adjustment semantics remain unapproved.                        |
| SO-013 Backend totals authority approval | PENDING_REVIEW  | PENDING_REVIEW  | TOP_25 review links sessions totals risks to backend totals evidence; production switch remains unapproved.    |

| Status          | Count |
| --------------- | ----: |
| APPROVED        |     0 |
| PENDING_REVIEW  |     6 |
| MANUAL_REQUIRED |    12 |
| BLOCKED         |     2 |
| REJECTED        |     0 |

Production-blocking signoffs remaining: 20.

Result: `PRODUCTION_NO_GO`

No signoff was changed to `APPROVED`.
